SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001615774-19-001031
Filing Date
2019-01-25
Accepted
2019-01-25 17:06:29
Documents
47
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A s115528_10ka.htm 10-K/A 337660
2 EXHIBIT 31.1 s115528_ex31-1.htm EX-31.1 9547
3 EXHIBIT 31.2 s115528_ex31-2.htm EX-31.2 9427
4 EXHIBIT 32.1 s115528_ex32-1.htm EX-32.1 4485
  Complete submission text file 0001615774-19-001031.txt   3379834

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE avxl-20180930.xml EX-101.INS 842291
6 XBRL SCHEMA FILE avxl-20180930.xsd EX-101.SCH 40580
7 XBRL CALCULATION FILE avxl-20180930_cal.xml EX-101.CAL 31997
8 XBRL DEFINITION FILE avxl-20180930_def.xml EX-101.DEF 122365
9 XBRL LABEL FILE avxl-20180930_lab.xml EX-101.LAB 315376
10 XBRL PRESENTATION FILE avxl-20180930_pre.xml EX-101.PRE 193941
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 001-37606 | Film No.: 19543211
SIC: 8731 Services-Commercial Physical & Biological Research